Schroder Investment Management Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-79,329
Closed -$4.82M 1344
2021
Q4
$4.82M Sell
79,329
-3,042
-4% -$181K 0.01% 771
2021
Q3
$5.25M Buy
82,371
+2,492
+3% +$157K 0.01% 779
2021
Q2
$5.01M Buy
79,879
+79,700
+44,525% +$5M 0.01% 828
2021
Q1
$10K Buy
+179
New +$9.69K ﹤0.01% 1499
2017
Q4
Sell
-915,745
Closed -$43.4M 1319
2017
Q3
$43.4M Sell
915,745
-313,119
-25% -$15.3M 0.08% 312
2017
Q2
$61M Sell
1,228,864
-38,456
-3% -$1.7M 0.11% 241
2017
Q1
$55.5M Buy
1,267,320
+263,056
+26% +$10.7M 0.1% 256
2016
Q4
$33.2M Buy
1,004,264
+915,161
+1,027% +$35.5M 0.06% 364
2016
Q3
$4.42M Buy
+89,103
New +$4.64M 0.01% 740

Other funds holding ACHC

Schroder Investment Management Group's ACHC Position: Q1 2022 in Review

Schroder Investment Management Group sold out of Acadia Healthcare (ACHC) in Q1 2022, closing a stake of 79,329 shares — an estimated $4.82M sold.

Schroder Investment Management Group first reported a position in ACHC in Q3 2016 and held it in 9 quarters. The position peaked at $61M in Q2 2017. 287 funds tracked by Wall St. Rank hold ACHC as of Q1 2022.

  • Schroder Investment Management Group reported no remaining Acadia Healthcare position as of Q1 2022 after selling out during the quarter.
  • Schroder Investment Management Group sold 79,329 Acadia Healthcare shares in Q1 2022, an estimated $4.82M.
  • Schroder Investment Management Group first reported a position in Acadia Healthcare in Q3 2016 and held it in 9 quarters.
  • Schroder Investment Management Group's Acadia Healthcare position peaked at $61M in Q2 2017.
  • 287 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2022.

Based on Schroder Investment Management Group's 13F filing for Q1 2022, filed 16 May 2022.